A Long-term Assessment of Safety and Physical Function with AMG 108 Subcutaneous Monthly Treatment in Subjects with Rheumatoid Arthritis

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003698-29

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective for this study is to assess long-term safety of AMG 108 (125mg, 250 mg) SC in subjects with RA previously enrolled in study 20050168


Critère d'inclusion

  • Rheumatoid arthritis (RA)